San Diego, CA (PRWEB) December 17, 2021 GB HealthWatch, a genetic-based preventive health company, announced today it raised $3.5 million in pre-series C
וַיִדוֹם אַהֲרֹן • מנדל ראטה שר להרוגי מירון kolhazman.co.il - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kolhazman.co.il Daily Mail and Mail on Sunday newspapers.
GB HealthWatch Launches Nutritional Genomics Analysis within Digital Health Platform to Combat Coronary Heart Disease, Obesity and Type 2 Diabetes prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Share:
GB HealthWatch collaborated with preventive cardiologists to explore and validate the clinical utility of its GBinsight comprehensive genetic testing and analysis. The impacts of genetics on clinical practice were presented by leading physicians at the 2020 National Lipid Association s Scientific Sessions.
SAN DIEGO (PRWEB) December 17, 2020 Genetics was a major theme of the National Lipid Association s (NLA) Scientific Sessions, December 2020. Genetic testing for lipid disorders, polygenic risk scores for atherosclerotic cardiovascular disease (ASCVD) and the implications of genetics on clinical care, medical ethics and identifying individuals at high risk and preventive strategies were among the headlining topics. The clinical utility of GBinsight comprehensive genetic testing and analysis was highlighted by several leading physicians and scientists throughout the sessions.